Related Experiment Video
Updated: Jul 6, 2026

10:09
Adjustable Stiffness, External Fixator for the Rat Femur Osteotomy and Segmental Bone Defect Models
Published on: October 9, 2014
Reuse of external fixation components: a randomized trial
Jinsil K Sung1, Rafael Levin, Jodi Siegel
1Boston Medical Center, Boston, MA 02118, USA.
Journal of Orthopaedic Trauma
|March 20, 2008
Summary
Refurbished external fixation devices are safe and effective, offering significant cost savings. This study found no difference in complications between new and reused components, demonstrating the viability of refurbishment programs.
Area of Science:
- Orthopedic surgery
- Biomedical engineering
- Health economics
Background:
- External fixation devices are crucial in trauma care but are costly single-use items in the US.
- Approved refurbishment processes exist for non-implantable components, presenting a potential cost-saving alternative.
Purpose of the Study:
- To evaluate the safety, efficacy, and fiscal impact of a refurbishment program for external fixation devices.
- To compare outcomes of new versus refurbished external fixation components in patients with fractures.
Main Methods:
- A randomized clinical trial was conducted at a Level I trauma center.
- 96 eligible patients with fractures were randomized to receive either new or refurbished external fixation components (all pins were new).
- Outcomes measured included pin tract infections, loss of fixation, and component loosening.
Main Results:
- No statistically significant differences were observed in pin tract infections (46% vs. 52%), loss of fixation (4% vs. 4%), or component loosening (1% vs. 1%) between new and refurbished frames.
- The study treated 96 fractures, including distal radius, pilon, and tibial plateau fractures.
Conclusions:
- Refurbishment programs for external fixation devices are safe and effective, with no compromise in clinical outcomes.
- This specific program demonstrated an actual cost saving of $65,452, with a potential to save 25% of the cost of all new frames.
- Patient acceptance remains a challenge, as 65% of eligible patients declined participation due to refurbished clamps.
